← USPTO Patent Grants

CLDN18.2 binding molecule

Grant US12595302B2 Kind: B2 Apr 07, 2026

Assignee

SANYOU BIOPHARMACEUTICALS CO., LTD.

Inventors

Yongcong Tan, Guojun Lang, Chao Kong, Chanjuan Liu, Min Deng, Qi Wu, Jing Zhang, Wenhai Zhang, Baoguo Fan

Abstract

Disclosed is a novel CLDN18.2 binding molecule. Also disclosed are a nucleic acid molecule encoding the CLDN18.2 binding molecule, an expression vector and a host cell for expressing the CLDN18.2 binding molecule. Further disclosed are a method for producing the CLDN18.2 binding molecule and use thereof.

CPC Classifications

C07K 16/28 C07K 2317/24 C07K 2317/565 C07K 2317/569 C07K 16/30 C07K 2317/22 C07K 2317/33 C07K 2317/34 C07K 2317/64 C07K 2317/732 C07K 2317/734 C07K 2317/76 C07K 2317/77 C07K 2317/92 A61P 35/00 A61K 39/00 A61K 2039/505 C12N 15/70 C12N 15/81 C12N 15/85

Filing Date

2020-05-21

Application No.

17613440

Claims

12

View original document →